Complete Nutrigenomics References
These are the references for the following posts:
[1] Corella D, et al. (2009). APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Archives of Internal Medicine, 169(20), 1897-1906.
[2] Zhang X, et al. (2012). FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: The POUNDS LOST Trial. Diabetes, 61(11), 3005-3011.
[3] Florez JC, et al. (2006). TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine, 355(3), 241-250.
[4] Luan J, et al. (2001). PPARG P12A polymorphism in the EPIC-Norfolk cohort: differential effects on body mass index in subjects with and without excess weight. International Journal of Obesity, 25(6), 822-828.
[5] Ordovas JM, et al. (1995). Apolipoprotein E polymorphism and fat intake: impact on diet-induced hypercholesterolemia. American Journal of Clinical Nutrition, 61(3), 597S-601S.
[6] Frosst P, et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10(1), 111-113.
[7] Enattah NS, et al. (2002). Identification of a variant associated with adult-type hypolactasia. Nature Genetics, 30(2), 233-237.
[8] Palli D, et al. (2005). GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. International Journal of Cancer, 115(2), 284-289.
[9] García-Martín E, et al. (2015). Diamine oxidase rs1049793 polymorphism is associated with the risk of histamine intolerance. British Journal of Clinical Pharmacology, 80(6), 1370-1377.
[10] Hopp K, et al. (2015). Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. Journal of the American Society of Nephrology, 26(10), 2559-2570.
[11] Binkley KE, et al. (2010). Salicylate sensitivity in chronic urticaria. Annals of Allergy, Asthma & Immunology, 105(2), 147-151.
[12] Wacklin P, et al. (2011). Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One, 6(5), e20113.
[13] Raboy V. (2009). Approaches and challenges to engineering seed phytate and total phosphorus. Plant Science, 177(4), 281-296.
[14] Ionescu G, et al. (2007). The HLA-DR association with mold sensitivity. Clinical & Experimental Allergy, 37(7), 1091-1095.
[15] Uitterlinden AG, et al. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338(2), 143-156.
[16] Wang TJ, et al. (2010). Common genetic determinants of vitamin D insufficiency: a genome-wide association study. The Lancet, 376(9736), 180-188.
[17] Schlingmann KP, et al. (2007). Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature Genetics, 31(2), 166-170.
[18] Kolisek M, et al. (2008). Mrs2p is an essential component of the major electrophoretic Mg2+ influx system in mitochondria. The EMBO Journal, 27(20), 2736-2746.
[19] Panicker V, et al. (2008). Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. The Journal of Clinical Endocrinology & Metabolism, 94(5), 1623-1629.
[20] Kopp P. (2013). Thyroid hormone synthesis. In: Feingold KR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.
[21] Monsuur AJ, et al. (2008). Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One, 3(5), e2270.
[22] Karell K, et al. (2003). HLA types in celiac disease patients not carrying the DQA105-DQB102 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Human Immunology, 64(4), 469-477.
[23] Schuppan D, et al. (2015). Non-celiac wheat sensitivity: differentiated diagnosis, triggers and implications. Best Practice & Research Clinical Gastroenterology, 29(3), 469-476.
[24] Quinzii CM, et al. (2014). Human CoQ10 deficiencies. BioFactors, 40(1), 389-401.
[25] Ross D, Siegel D. (2017). Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch. Frontiers in Physiology, 8, 595.
[26] Peltekova VD, et al. (2004). Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genetics, 36(5), 471-475.
[27] Bonnefont JP, et al. (2004). Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Molecular Aspects of Medicine, 25(5-6), 495-520.
[28] Vakhapova V, et al. (2011). Phosphatidylserine containing ω–3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dementia and Geriatric Cognitive Disorders, 31(5), 295-303.
[29] Cantó C, et al. (2015). NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metabolism, 22(1), 31-53.
[30] Rung J, et al. (2009). Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nature Genetics, 41(10), 1110-1115.
[31] Deeb SS, et al. (1998). A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics, 20(3), 284-287.
[32] Frayling TM, et al. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316(5826), 889-894.
[33] Hoffstedt J, et al. (2002). A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Hormone and Metabolic Research, 34(7), 355-359.
[34] Clément K, et al. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 392(6674), 398-401.
[35] Ukkola O, et al. (2001). Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. The Journal of Clinical Endocrinology & Metabolism, 86(8), 3996-3999.
[36] Loos RJ, et al. (2008). Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics, 40(6), 768-775.
[37] Augustin LS, et al. (2015). Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutrition, Metabolism and Cardiovascular Diseases, 25(9), 795-815.
[38] Flachs P, et al. (2009). Cellular and molecular effects of n−3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Science, 116(1), 1-16.
[39] Anderson RA. (2008). Chromium and polyphenols from cinnamon improve insulin sensitivity. Proceedings of the Nutrition Society, 67(1), 48-53.
[40] Sutton EF, et al. (2018). Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metabolism, 27(6), 1212-1221.e3.
[41] Rebello CJ, et al. (2013). Dietary strategies to increase satiety. Advances in Food and Nutrition Research, 69, 105-182.
[42] Leidy HJ, et al. (2015). The role of protein in weight loss and maintenance. The American Journal of Clinical Nutrition, 101(6), 1320S-1329S.
[43] Shapiro A, et al. (2008). Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 295(5), R1370-R1375.
[44] Martins MA, et al. (2017). Effects of fish oil supplementation on inflammatory markers, leptin, and insulin resistance in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 9, 100.
[45] Leidy HJ, Campbell WW. (2011). The effect of eating frequency on appetite control and food intake: brief synopsis of controlled feeding studies. The Journal of Nutrition, 141(1), 154-157.
[46] Rolls BJ. (2009). The relationship between dietary energy density and energy intake. Physiology & Behavior, 97(5), 609-615.
[47] Paddon-Jones D, et al. (2008). Protein, weight management, and satiety. The American Journal of Clinical Nutrition, 87(5), 1558S-1561S.
[48] Hollands GJ, et al. (2015). Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. Cochrane Database of Systematic Reviews, (9).
[49] McKiernan F, et al. (2009). Thirst-drinking, hunger-eating; tight coupling? Journal of the American Dietetic Association, 109(3), 486-490.
[50] Taheri S, et al. (2004). Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine, 1(3), e62.
[51] Adam TC, Epel ES. (2007). Stress, eating and the reward system. Physiology & Behavior, 91(4), 449-458.
[52] Strasser B, Pesta D. (2013). Resistance training for diabetes prevention and therapy: experimental findings and molecular mechanisms. BioMed Research International, 2013, 805217.
[65] Lan J, et al. (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69-81.
[66] Akbari M, et al. (2018). The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism, 87, 56-69.
[67] Gray B, et al. (2013). Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. European Journal of Clinical Nutrition, 67(12), 1234-1242.
[68] Rondanelli M, et al. (2012). Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration. Eating and Weight Disorders, 17(1), e22-e28.
[69] Ward E. (2014). Addressing nutritional gaps with multivitamin and mineral supplements. Nutrition Journal, 13, 72.
[70] Leung WC, et al. (2009). Two common single nucleotide polymorphisms in the gene encoding β-carotene 15,15'-monoxygenase alter β-carotene metabolism in female volunteers. The FASEB Journal, 23(4), 1041-1053.
[71] Mathias RA, et al. (2011). FADS genetic variants and ω-6 polyunsaturated fatty acid metabolism in a homogeneous island population. Journal of Lipid Research, 52(11), 2113-2120.
[72] Allen KJ, et al. (2008). Iron-overload-related disease in HFE hereditary hemochromatosis. New England Journal of Medicine, 358(3), 221-230.
[73] Flannick J, et al. (2014). Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nature Genetics, 46(4), 357-363.
[74] Tanaka T, et al. (2009). Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. American Journal of Human Genetics, 84(4), 477-482.
[75] Hazra A, et al. (2008). Common variants of FUT2 are associated with plasma vitamin B12 levels. Nature Genetics, 40(10), 1160-1162.
[76] Lachman HM, et al. (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6(3), 243-250.
[77] Miller AA, et al. (2012). The effects of green tea on catechol-O-methyltransferase activity and norepinephrine levels in rats. Nutritional Neuroscience, 15(4), 163-169.
[78] Kling P, et al. (2016). Genetic variation in the methylenetetrahydrofolate reductase gene (MTHFR) affects trigeminal pain processing. PLOS One, 11(3), e0150872.
[79] Tunbridge EM, et al. (2006). Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry, 60(2), 141-151.
[80] Stein DJ, et al. (2006). Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy. CNS Spectrums, 11(1), 17-23.